We hereby inform that the Company has received the requisite approval from MIDC on January 31, 2025 ("Transfer Order"). The Company will take steps to complete the transaction by assigning its unexpired leasehold rights in the Land and transferring its ownership rights in the Buildings, in favour of Zoetis in accordance with the transfer order issued by MIDC.

pdf

Pfizer Ltd.

01 Feb 2025, 03:52AM

4299.80

0.16%

Pfizer resolves conservative challenge to diversity fellowship program

livemint

PFIZER-LAWSUIT/DIVERSITY (PIX):Pfizer resolves conservat

Number of FII/FPI investors decreased from 151 to 129 in Mar 2025 qtr

Pfizer Q3 results: Net profit falls 2% to Rs 128 cr, revenue at Rs 538 cr

Business Standard | 31 Jan 2025, 09:25PM 1 more

Pfizer Ltd.

31 Jan 2025, 07:06PM

4299.80

0.16%

Company Update

PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Change in Senior Management Personnel

pdf

Pfizer Ltd.

31 Jan 2025, 05:04PM

4299.80

0.16%

Board Meeting

PFIZER LTD. - 500680 - Board Meeting Outcome for Outcome Of The Board Meeting- Unaudited Financial …

BSE India

Outcome of the Board Meeting- Unaudited Financial Results for the quarter and nine months ended December 31, 2024

pdf

Pfizer Ltd.

27 Jan 2025

4299.80

0.16%

Pfizer Dodges Challenge to Its Board in Battle With Starboard

livemint

Pfizer Inc. got a reprieve at least for now in its battle with activist investor Starboard Value LP, according to people familiar with the matter.

Pfizer Ltd. is trading below its 100 day SMA of 4506.6

Pfizer Ltd.

24 Jan 2025

4299.80

0.16%

Board Meeting

PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting To Consider And Take On …

BSE India

PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve Board Meeting to consider and take on record the Unaudited Financial Results for the quarter and nine months ended December 31, 2024

pdf

Pfizer Ltd.

14 Jan 2025

4299.80

0.16%

Company Update

PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended December 31, 2024

pdf

Pfizer Ltd.

30 Dec 2024, 08:33PM

4299.80

0.16%

SAST

PFIZER LTD. - 500680 - Closure of Trading Window

BSE India

We would like to inform you that, for the purpose of declaration of unaudited financial results for the quarter and nine months ending December 31, 2024, the trading window of the Company shall remain closed from Tuesday December 31, 2024 (close of business hours) till 48 hours after the financial results are made public.

pdf

Pfizer Ltd.

17 Dec 2024

4299.80

0.16%

In relief for investors, Pfizer 2025 profit forecast in line with estimates

Business Standard

Shares of the drugmaker rose nearly 3 per cent to $25.98 in premarket trading after the company also said it was expecting 2025 sales of its Covid-19 vaccine and drug to be consistent

Number of FII/FPI investors decreased from 151 to 129 in Mar 2025 qtr

Is Pfizer Ltd. worth buying?

202 Votes:

Buy 75.25%

Sell 14.85%

Hold 9.9%